Planas, A.; Simó-Servat, O.; Hernández, C.; Ortiz-Zúñiga, Á.; Marsal, J.R.; Herance, J.R.; Ferreira-González, I.; Simó, R.
Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients. J. Pers. Med. 2021, 11, 1344.
https://doi.org/10.3390/jpm11121344
AMA Style
Planas A, Simó-Servat O, Hernández C, Ortiz-Zúñiga Á, Marsal JR, Herance JR, Ferreira-González I, Simó R.
Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients. Journal of Personalized Medicine. 2021; 11(12):1344.
https://doi.org/10.3390/jpm11121344
Chicago/Turabian Style
Planas, Alejandra, Olga Simó-Servat, Cristina Hernández, Ángel Ortiz-Zúñiga, Joan Ramón Marsal, José R. Herance, Ignacio Ferreira-González, and Rafael Simó.
2021. "Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients" Journal of Personalized Medicine 11, no. 12: 1344.
https://doi.org/10.3390/jpm11121344
APA Style
Planas, A., Simó-Servat, O., Hernández, C., Ortiz-Zúñiga, Á., Marsal, J. R., Herance, J. R., Ferreira-González, I., & Simó, R.
(2021). Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients. Journal of Personalized Medicine, 11(12), 1344.
https://doi.org/10.3390/jpm11121344
